Publication | Closed Access
A Prospective Open-Label Trial of Extended-Release Carbamazepine Monotherapy in Children with Bipolar Disorder
83
Citations
41
References
2010
Year
Open-label CBZ-ER treatment was beneficial for the treatment of BD in children. Future controlled trials are warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1